Clinical Trial Update: Evaluate the Impact, Safety, Tolerability and Immunogenicity of the Coronavac Vaccine in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Coronavac vaccine in kidney transplant recipients, focusing on impact, safety, tolerability, and immunogenicity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• CoronaVac (Inactivated SARS-CoV-2 vaccine)

Snippet

Sponsor: Hospital do Rim e Hipertensão | Conditions: SARS-CoV Infection, Coronavirus Infection | Phase 4 | Status: UNKNOWN